NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/26/2026
Back to search
Official data from USPTO
EPI.NEO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EPI.NEO
ST13
US500000079195452Class
5, 10, 42, 44
Filing
79195452
Registration
5268456
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/26/2026
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
06/30/2016
Registration date
08/22/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2024
Last transaction
03/08/2024
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
SALES, HEATHER
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Epimune GmbH
Epiontis GmbH
Representatives
Richard P. Georget, Esq.
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for use in medical diagnostic in the field of immunology; kits containing reagents for use in medical diagnostic in the field of immunologic diseases
Class 10
Apparatus and instruments for medical diagnostic purposes in the field of immunology
Class 42
Quality control for medical purposes in the field of immunology; scientific research in the field of medicineimmunology
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
38 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
12/21/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/26/2024
INPC
INVALIDATION PROCESSED
11/26/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/09/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/21/2024
C71T
CANCELLED SECTION 71
03/08/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/25/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/26/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/29/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/07/2017
FIMP
FINAL DISPOSITION PROCESSED
12/07/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/22/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2017
PUBO
PUBLISHED FOR OPPOSITION
06/06/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/26/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
04/25/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/25/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
04/25/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/25/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/09/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/09/2017
RFNP
REFUSAL PROCESSED BY IB
12/02/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/15/2016
RFRR
REFUSAL PROCESSED BY MPU
11/15/2016
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/09/2016
CNRT
NON-FINAL ACTION WRITTEN
11/08/2016
DOCK
ASSIGNED TO EXAMINER
11/07/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/03/2016
Continuous trademark protection
Get notified about every new filing that threatens EPI.NEO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.